NPH insulin
Selected indexed studies
- (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. (Cochrane Database Syst Rev, 2020) [PMID:33166419]
- Safety and efficacy of insulin detemir versus NPH in the treatment of diabetes during pregnancy: Systematic review and meta-analysis of randomized controlled trials. (Diabetes Res Clin Pract, 2022) [PMID:35878788]
- Safety and efficacy of insulin detemir vs. insulin NPH in pregnant women with diabetes: a systematic review and meta-analysis. (Minerva Obstet Gynecol, 2024) [PMID:37877940]
_Worker-drafted node — pending editorial review._
Connections
NPH insulin is a side effect of
Sources
- (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. (2020) pubmed
- Safety and efficacy of insulin detemir versus NPH in the treatment of diabetes during pregnancy: Systematic review and meta-analysis of randomized controlled trials. (2022) pubmed
- Safety and efficacy of insulin detemir vs. insulin NPH in pregnant women with diabetes: a systematic review and meta-analysis. (2024) pubmed
- Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. (2007) pubmed
- Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. (2009) pubmed
- Insulin glargine versus NPH insulin in patients with type 1 diabetes. (2003) pubmed
- NPH insulin. (1950) pubmed
- NPH insulin. (1951) pubmed
- Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis. (2008) pubmed
- Comparison of insulin glargine and NPH insulin in the treatment of type 2 diabetes: a review of clinical studies. (2007) pubmed